These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6979991)

  • 21. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Anguiano JB
    Psychiatry Res; 2007 May; 151(1-2):163-8. PubMed ID: 17434602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
    Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
    Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hallucinations, consciousness and psychosis].
    Del Cul A; Gaillard R; Jardri R; Fossati P
    Encephale; 2010 Sep; 36(4):348-54. PubMed ID: 20850607
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum prolactin and smoking status in chronic antipsychotic-treated male patients with schizophrenia.
    Zhang X; Bu R; Sha W; Wang X; Liu J; Chu X; Li J; Dong H; Liu Y; Qing J
    Psychiatry Res; 2013 Sep; 209(2):239-41. PubMed ID: 23684052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between cognitive biases and psychological dimensions of delusions: The importance of jumping to conclusions.
    Gawęda Ł; Staszkiewicz M; Balzan RP
    J Behav Ther Exp Psychiatry; 2017 Sep; 56():51-56. PubMed ID: 27527489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine uptake by platelets from subjects with schizophrenia: a correlation with the delusional state of the patient.
    Dean B; Kulkarni J; Copolov DL; Shrikanthan P; Malone V; Hill C
    Psychiatry Res; 1992 Jan; 41(1):17-24. PubMed ID: 1561286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
    Davis BM; Davis KL; Mohs RC; Mathé AA; Rothpearl AB; Johns CA; Levy MI; Horvath TB
    Arch Gen Psychiatry; 1985 Mar; 42(3):259-64. PubMed ID: 3977547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schizophrenia: an information processing model.
    Carr V; Wale J
    Aust N Z J Psychiatry; 1986 Jun; 20(2):136-55. PubMed ID: 3464263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hallucinations, delusions, and thought disorder among adult psychiatric inpatients with a history of child abuse.
    Read J; Argyle N
    Psychiatr Serv; 1999 Nov; 50(11):1467-72. PubMed ID: 10543857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of impaired reality processing with psychotic symptoms in schizophrenia.
    Lee JS; Chun JW; Lee SH; Kang DI; Kim JJ
    Psychiatry Res; 2013 Dec; 210(3):721-8. PubMed ID: 23992791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizophrenic psychosis and associated aqueduct stenosis.
    O'Flaithbheartaigh S; Williams PA; Jones GH
    Br J Psychiatry; 1994 May; 164(5):684-6. PubMed ID: 7921723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study on serum prolactin levels in schizophrenia: correlation with positive and negative symptoms.
    Kuruvilla A; Srikrishna G; Peedicayil J; Kuruvilla K; Kanagasabapathy AS
    Int Clin Psychopharmacol; 1993; 8(3):177-9. PubMed ID: 8263315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of prolactin by dopamine agonists in schizophrenics and controls.
    Rotrosen J; Angrist B; Clark C; Gershon S; Halpers FS; Sachar EJ
    Am J Psychiatry; 1978 Aug; 135(8):949-51. PubMed ID: 665840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression.
    Sax KW; Strakowski SM; Keck PE; Upadhyaya VH; West SA; McElroy SL
    Br J Psychiatry; 1996 Jan; 168(1):68-71. PubMed ID: 8770431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
    Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
    Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
    [No Abstract]   [Full Text] [Related]  

  • 37. Toward a new approach to schizophrenic psychosis.
    Morin DC
    Psychol Rep; 1995 Feb; 76(1):123-9. PubMed ID: 7770554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive behaviour therapy of schizophrenia. The amenability of delusions and hallucinations to reasoning.
    Kingdon D; Turkington D; John C
    Br J Psychiatry; 1994 May; 164(5):581-7. PubMed ID: 7802805
    [No Abstract]   [Full Text] [Related]  

  • 40. The psychopathology of 'late schizophrenia'.
    Marneros A; Deister A
    Psychopathology; 1984; 17(5-6):264-74. PubMed ID: 6537542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.